Suchit Jhunjhunwala

Title: Suchit Jhunjhunwala: Innovator in Immunogenic Peptide Identification

Introduction

Suchit Jhunjhunwala is a prominent inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of immunotherapy, particularly in the identification of disease-specific immunogenic peptides. With a total of 2 patents, his work is paving the way for advancements in personalized medicine.

Latest Patents

Jhunjhunwala's latest patents focus on the identification of immunogenic mutant peptides using genomic, transcriptomic, and proteomic information. The present disclosure provides methods for identifying disease-specific immunogenic peptides through a series of selection steps. The immunogenic epitopes identified by these methods are applicable for use in peptide-based immunotherapy, especially in cancer therapy. Furthermore, these methods can be performed in a high-throughput manner, serving as a means for personalized vaccine development and therapy. The patents also include compositions of immunogenic peptides and methods of treatment comprising these compositions.

Career Highlights

Throughout his career, Jhunjhunwala has worked with notable companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these leading organizations has contributed to his expertise in the field of immunotherapy and peptide research.

Collaborations

Some of his notable coworkers include Lelia Delamarre and Patrick J Lupardus. Their collaboration has likely enhanced the innovative approaches taken in their research endeavors.

Conclusion

Suchit Jhunjhunwala's work in the identification of immunogenic peptides represents a significant advancement in cancer therapy and personalized medicine. His contributions are vital for the future of immunotherapy and the development of effective treatments.